Biorenixsp. z o.o.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2003-11-13
Share capital
50,000.00 PLN
Registered address
św. Ducha 5A/11, 70-205 Szczecin, Poland

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2023, 3 days late).

  • 202514/07/2026
  • 202430/06/2025
  • 202318/07/2024
  • 202207/07/2023
  • 202113/07/2022
  • 202011/08/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 39.11kMedianUSD 443.18kAverageUSD 1.74m
Net profit
This companyUSD 484.90MedianUSD 14.27kAverageUSD 128.63k
Operating costs
This companyUSD 38.62kMedianUSD 395.77kAverageUSD 1.56m
Assets
This companyUSD 2.60kMedianUSD 173.69kAverageUSD 1.02m

Trademarks

Biorenix currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 1993.

MarkNumberClassesStatusProtected until
BIORENIXZ.1191440, 10, 11, 37, 41, 42Expired –
MarkProtected until
BIORENIX–

Authorized Representatives

Krzysztof Piotr Kikiewicz – President of the Management Board

Manner of representation

The President of the Management Board–independent representation, or two members of the management board jointly, or one member of the management board jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Danuta Kikiewiczage 75
50$6,753.1150%
Krzysztof Piotr Kikiewiczage 52
50$6,753.1150%

Danuta Kikiewicz and Krzysztof Piotr Kikiewicz hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $2,264.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Makmentissp. z o.o.
Novum Kardiologiasp. z o.o.
Mediseasp. z o.o.
Ticket to Lasp. z o.o.
Sensusbalanssp. z o.o.
Telecardiosp. z o.o. + limited partnership
Oromedicasp. z o.o.
Poliklinika Śremsp. z o.o.
Mkmedicsp. z o.o.
Nomedikasp. z o.o.

Change history

DateEvent
2020-09-29Switch to PKD 2007
2008-08-12Address change
2006-02-14Share capital increase
2003-11-13Entered in the register

FAQ

Last updated: 2026-10-15